American Kidney Fund Highlights Critical Public Health Education Programs at ASN Kidney Week, Booth #2717
07. November 2019 09:00 ET
|
American Kidney Fund
WASHINGTON, D.C., Nov. 07, 2019 (GLOBE NEWSWIRE) -- At the American Society of Nephrology (ASN) Kidney Week 2019 Annual Meeting in Washington, D.C., the American Kidney Fund (AKF) is launching its...
Beyond Bananas™: American Kidney Fund Launches Campaign to Help Kidney Patients Reduce Risk and Effects of Hyperkalemia
26. August 2019 10:08 ET
|
American Kidney Fund
Rockville, Md., Aug. 26, 2019 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today launched a new health education campaign, Beyond Bananas™, to increase kidney patients’ understanding of high...
American Kidney Fund and AstraZeneca Announce Campaign to Expand Education and Awareness of Hyperkalemia in Patients with Kidney Disease
29. Mai 2019 10:41 ET
|
American Kidney Fund
Rockville, Md., May 29, 2019 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today announced AstraZeneca as the founding supporter to develop an education and awareness campaign that will aim...
Relypsa Announces Presentation of New Clinical and Real-World Analyses of Veltassa® at AMCP Nexus 2018
22. Oktober 2018 08:00 ET
|
Relypsa, Inc.
REDWOOD CITY, Calif., Oct. 22, 2018 (GLOBE NEWSWIRE) -- Relypsa, Inc., a Vifor Pharma Group company, will present new data on Veltassa® (patiromer) at the Academy of Managed Care Pharmacy’s AMCP...
Relypsa Announces Presentation of New Clinical and Real-World Analyses of Veltassa® at ASN Kidney Week 2018
09. Oktober 2018 16:00 ET
|
Relypsa, Inc.
REDWOOD CITY, Calif., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Relypsa, Inc., a Vifor Pharma Group company, will present new data on Veltassa® (patiromer) at the American Society of Nephrology (ASN) Kidney...
American Kidney Fund Launches Comprehensive New Kidney Disease Education Portal
16. Mai 2018 11:30 ET
|
American Kidney Fund
ROCKVILLE, Md., May 16, 2018 (GLOBE NEWSWIRE) -- The American Kidney Fund (AFK) today unveiled CKD Central, a new free online education portal offering comprehensive information and resources on...
Relypsa Announces FDA Approval of Supplemental New Drug Application to Enable the Usage of Veltassa® (patiromer) With or Without Food
08. Mai 2018 08:00 ET
|
Relypsa, Inc.
REDWOOD CITY, Calif., May 08, 2018 (GLOBE NEWSWIRE) -- Relypsa, Inc., a Vifor Pharma Group company, today announced that the United States (U.S) Food and Drug Administration (FDA) approved a...
Relypsa Presents Patiromer Clinical Trial Data on Serum Potassium in Patients with Hyperkalemia at the National Kidney Foundation 2018 Spring Clinical Meetings
11. April 2018 08:00 ET
|
Relypsa, Inc.
REDWOOD CITY, Calif., April 11, 2018 (GLOBE NEWSWIRE) -- Relypsa, Inc., a Vifor Pharma Group company, today announced results from a pooled analysis of three clinical trials evaluating the effects...
Relypsa Names Sylvia R. Wheeler V.P. Investor Relations and Corporate Affairs
02. April 2014 09:00 ET
|
Relypsa, Inc.
REDWOOD CITY, Calif., April 2, 2014 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced the appointment of Sylvia R. Wheeler to the position of Vice...